Prolotherapy vs Steroid Injections

Prolotherapy vs. Steroid Injections: Which Is Better for SI Joint Pain?

If you’ve been dealing with sacroiliac (SI) joint pain, you’ve probably heard about steroid injections. But what about prolotherapy? Could it offer longer-lasting relief?

Both treatments involve injections, but they approach pain management differently. While steroid injections are commonly used to reduce inflammation, prolotherapy aims to stimulate a healing response in the tissues surrounding the joint.

A randomized clinical trial comparing these two approaches found some interesting results. Here’s what patients should know.

What’s the Difference Between Prolotherapy and Steroid Injections?

Steroid injections deliver corticosteroid medication into the SI joint to reduce inflammation and relieve pain. For some patients, they provide significant relief, although the duration varies considerably. Steroid injections are also sometimes used as part of the diagnostic process, typically alongside a local anesthetic.

Prolotherapy involves injecting a solution, commonly containing dextrose (a type of sugar), into targeted tissues. The proposed goal is to stimulate a localized healing response that may help address pain associated with ligaments and other connective tissues.

Unlike corticosteroid injections, which primarily target inflammation, prolotherapy is intended to encourage tissue repair. However, whether prolotherapy reliably strengthens SI joint ligaments or improves joint stability remains uncertain.

What Does the Research Say?

A 2010 randomized controlled trial published in the Journal of Alternative and Complementary Medicine compared prolotherapy with corticosteroid injections in patients experiencing SI joint pain.

The study, conducted by Kim and colleagues, enrolled 48 patients with SI joint pain lasting at least three months.

Participants were randomly assigned to receive either intra-articular dextrose prolotherapy or a corticosteroid injection.

Both groups experienced improvements in pain and disability shortly after treatment. However, the researchers found differences in how long those improvements lasted.

At the 15-month follow-up, 58.7% of patients in the prolotherapy group reported at least a 50% reduction in pain, compared with 10.2% in the corticosteroid group.

These results suggest that prolotherapy may offer longer-lasting pain relief for some patients.

However, there’s an important distinction between promising research and established medical recommendations.

Does This Mean Prolotherapy Is Better?

Not necessarily.

Although the results were encouraging, this was a relatively small study. Larger, well-designed trials are needed to confirm whether prolotherapy consistently provides better long-term outcomes.

The study also doesn’t establish that prolotherapy can repair damaged ligaments, correct SI joint instability, or address every underlying cause of SI joint dysfunction.

SI joint pain can involve several contributing factors, including inflammation, degenerative changes, altered joint mechanics, and problems involving surrounding ligaments.

A treatment that helps one patient may provide little benefit to another.

What About Safety?

Both procedures carry potential risks.

Steroid injections may cause temporary increases in pain, infection, bleeding, or steroid-related side effects. Repeated corticosteroid exposure also requires consideration, particularly in patients with certain medical conditions.

Prolotherapy may cause temporary soreness, swelling, or increased pain following treatment. As with other injections, infection, bleeding, and injury to surrounding structures are possible.

The available evidence is not sufficient to establish that prolotherapy is safer than corticosteroid injections for SI joint pain.

Patients considering either procedure should discuss the potential benefits, risks, and limitations with a qualified healthcare professional.

What Should SI Joint Pain Patients Take Away From This?

The research suggests that prolotherapy may be worth discussing with a healthcare professional, particularly for patients who haven’t experienced lasting relief from other conservative treatments.

However, prolotherapy is not currently established as a superior treatment for SI joint dysfunction, and the available evidence remains limited.

Understanding the underlying cause of your pain is essential when evaluating treatment options.

For patients navigating SI joint dysfunction, the goal isn’t simply to find another injection. It’s to identify treatments supported by evidence that make sense for their individual circumstances.

We’d Love to Hear From You!

Have you tried steroid injections, prolotherapy, or both for SI joint pain?

Did either treatment provide relief? If so, how long did it last?

Share your experience in the comments. Patient experiences don’t replace clinical research, but they can help others feel less alone and prepare more informed questions for their healthcare providers.

📚 Research Reference

Kim WM, Lee HG, Jeong CW, Kim CM, Yoon MH. (2010). A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain.

Journal of Alternative and Complementary Medicine, 16(12), 1285–1290.

⁠Find the study on PubMed

Disclaimer: This article is provided for educational purposes only and does not constitute medical advice. Treatment decisions should be made in consultation with a qualified healthcare professional.

Next
Next

What Are SI Joint Provocation Tests?